awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q54981236-022444BC-759A-401F-9626-4ED201D6311B
Q54981236-022444BC-759A-401F-9626-4ED201D6311B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54981236-022444BC-759A-401F-9626-4ED201D6311B
Immune consequences of anti-angiogenic therapyin renal cell carcinoma.
P2860
Q54981236-022444BC-759A-401F-9626-4ED201D6311B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54981236-022444BC-759A-401F-9626-4ED201D6311B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eacda288614aa264260b762b77afe32c25482490
P2860
Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial.